首页> 外文期刊>Interdisciplinary Sciences: Computational Life Sciences >Construction and Identification of the RNAi Recombinant Lentiviral Vector Targeting Human DEPDC7 Gene
【24h】

Construction and Identification of the RNAi Recombinant Lentiviral Vector Targeting Human DEPDC7 Gene

机译:RNAi重组慢病毒载体靶向人DEPDC7基因的构建与鉴定

获取原文
获取原文并翻译 | 示例
       

摘要

Human DEP domain containing 7 (DEPDC7) gene was originally found expressing high in liver tissue and low in most other tissues, but its function was largely unknown. In this study, we construct an RNA interference (RNAi) recombinant lentiviral vector particle targeting DEPDC7 in order to knockdown its gene expression in human hepatocellular carcinoma cell line HepG2. We screened three RNAi sequences targeting DEPDC7 and a scramble sequence by the aid of short hairpin RNAs (shRNA) design tools. Then, these sequences were separately cloned into the pLV-H1-EF1 alpha-puro vector to construct four lentiviral vectors (pshRNA-DEPDC7-NC, pshRNA-DEPDC7-RNAi1, pshRNA-DEPDC7-RNAi2 and pshRNA-DEPDC7-RNAi3). All of the recombinant plasmids were identified and confirmed by double digestion and DNA sequencing. After infecting HepG2 cells, the DEPDC7 mRNA and protein expression levels were examined by real-time PCR and western blot, respectively, and the gene expression was significantly down-regulated at both levels (P < 0.01). Cell motility and invasiveness were detected by Matrigel migration and invasion assay, and the results revealed that migration and invasion of HepG2 cells were significantly increased (P < 0.05). Our study showed successful construction of three lentiviral RNAi vectors targeting DEPDC7 gene and shRNA-mediated knockdown of DEPDC7 enable promotion of cell migration and invasion.
机译:含有7个(DEPDC7)基因的人DEP结构域最初发现在肝组织中表达高,在大多数其他组织中低,但其功能在很大程度上是未知的。在这项研究中,我们构建RNA干扰(RNAi)重组慢病毒载体粒子靶向DEPDC7,以便在人肝细胞癌细胞系Hepg2中敲低其基因表达。通过短发夹RNA(ShRNA)设计工具,我们筛选了靶向DEPDC7的三个RNAi序列和争吵序列。然后,将这些序列分别克隆到PLV-H1-EF1α-丙烃载体中以构建四个慢病毒载体(PSHRNA-DEPDC7-NC,PSHRNA-DEPDC7-RNAI1,PSHRNA-DEPDC7-RNAI2和PSHRNA-DEPDC7-RNAi3)。通过双重消化和DNA测序鉴定所有重组质粒并证实。感染HEPG2细胞后,通过实时PCR和Western印迹检查DepdC7 mRNA和蛋白质表达水平,并且基因表达在两个水平下显着下调(P <0.01)。通过Matrigel迁移和侵袭测定检测细胞活性和侵袭,结果表明,HepG2细胞的迁移和侵袭显着增加(P <0.05)。我们的研究表明,靶向DEPDC7基因的三个慢病毒RNAi载体的成功构建,SHRNA介导的DEPDC7敲低抗敲击,促进细胞迁移和侵袭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号